Near-infrared photoactivatable control of Ca signaling and optogenetic immunomodulation by He, Lian et al.
University of Massachusetts Medical School 
eScholarship@UMMS 
Open Access Articles Open Access Publications by UMMS Authors 
2015-12-08 
Near-infrared photoactivatable control of Ca signaling and 
optogenetic immunomodulation 
Lian He 
Texas A&M University Health Science Center 
Et al. 
Let us know how access to this document benefits you. 
Follow this and additional works at: https://escholarship.umassmed.edu/oapubs 
 Part of the Biochemistry Commons, Cell Biology Commons, and the Genetics Commons 
Repository Citation 
He L, Zhang Y, Ma G, Tan P, Li ZJ, Zhang S, Wu X, Jing J, Fang S, Zhou L, Wang Y, Huang Y, Hogan P, Han G, 
Zhou Y. (2015). Near-infrared photoactivatable control of Ca signaling and optogenetic 
immunomodulation. Open Access Articles. https://doi.org/10.7554/eLife.10024. Retrieved from 
https://escholarship.umassmed.edu/oapubs/2645 
Creative Commons License 
This work is licensed under a Creative Commons Attribution 4.0 License. 
This material is brought to you by eScholarship@UMMS. It has been accepted for inclusion in Open Access Articles 
by an authorized administrator of eScholarship@UMMS. For more information, please contact 
Lisa.Palmer@umassmed.edu. 
*For correspondence:Gang.
Han@umassmed.edu (GH);
yzhou@ibt.tamhsc.edu (YZ)
†These authors contributed
equally to this work
Competing interests: The
authors declare that no
competing interests exist
Funding: See page 23
Received: 11 July 2015
Accepted: 06 November 2015
Published: 08 December 2015
Reviewing editor: Richard
Aldrich, The University of Texas,
Austin, United States
Copyright He et al. This article
is distributed under the terms of
the Creative Commons
Attribution License, which
permits unrestricted use and
redistribution provided that the
original author and source are
credited.
Near-infrared photoactivatable control of
Ca2+ signaling and optogenetic
immunomodulation
Lian He1†, Yuanwei Zhang2†, Guolin Ma1†, Peng Tan1†, Zhanjun Li2,
Shengbing Zang1, Xiang Wu2, Ji Jing1, Shaohai Fang1, Lijuan Zhou3,
Youjun Wang3, Yun Huang1, Patrick G Hogan4, Gang Han2*, Yubin Zhou1,5*
1Institute of Biosciences and Technology, Texas A&M University Health Science
Center, Houston, United States; 2Department of Biochemistry and Molecular
Pharmacology, University of Massachusetts Medical School, Worcester, United
States; 3Beijing Key Laboratory of Gene Resource and Molecular Development,
College of Life Sciences, Beijing Normal University, Beijing, China; 4Division of
Signaling and Gene Expression, La Jolla Institute for Allergy and Immunology, La
Jolla, United States; 5Department of Medical Physiology, College of Medicine,
Texas A&M University Health Science Center, Temple, United States
Abstract The application of current channelrhodopsin-based optogenetic tools is limited by the
lack of strict ion selectivity and the inability to extend the spectra sensitivity into the near-infrared
(NIR) tissue transmissible range. Here we present an NIR-stimulable optogenetic platform (termed
’Opto-CRAC’) that selectively and remotely controls Ca2+ oscillations and Ca2+-responsive gene
expression to regulate the function of non-excitable cells, including T lymphocytes, macrophages
and dendritic cells. When coupled to upconversion nanoparticles, the optogenetic operation
window is shifted from the visible range to NIR wavelengths to enable wireless photoactivation of
Ca2+-dependent signaling and optogenetic modulation of immunoinflammatory responses. In a
mouse model of melanoma by using ovalbumin as surrogate tumor antigen, Opto-CRAC has been
shown to act as a genetically-encoded ’photoactivatable adjuvant’ to improve antigen-specific
immune responses to specifically destruct tumor cells. Our study represents a solid step forward
towards the goal of achieving remote and wireless control of Ca2+-modulated activities with
tailored function.
DOI:10.7554/eLife.10024.001
Introduction
Microbial opsin-based optogenetic technologies have been widely adopted to modulate neural
activity (Fenno et al., 2011), but similar tools tailored for utilization in non-excitable tissues (e.g., the
immune and hematopoietic system) are still limited. The application of channelrhodopsin (ChR)-
based optogenetic tools is limited by the lack of ion selectivity and the inability to extend the spec-
tral sensitivity into the near-infrared (NIR) range (Fenno et al., 2011). Here we present a tissue pene-
trable near infrared-stimulable optogenetic platform (termed ’Opto-CRAC’) that can be used to
reversibly photo-manipulate Ca2+ influx through one of the most Ca2+-selective ion channels, the
Ca2+ release-activated Ca2+ (CRAC) channel, which is abundantly present in most non-excitable cells
(Hogan et al., 2010; Prakriya and Lewis, 2015). Our tool is based on the engineering of light sensi-
tivity into the CRAC channel and its subsequent coupling to lanthanide-doped upconversion nano-
particles (UCNP), the latter of which act as nanotransducers to convert tissue penetrable NIR light
into visible light emission (Shen et al., 2013; Chen et al., 2014). We demonstrate that Opto-CRAC
He et al. eLife 2015;4:e10024. DOI: 10.7554/eLife.10024 1 of 25
TOOLS AND RESOURCES
tools can be applied to remotely control Ca2+ influx and generate repetitive Ca2+ oscillations,
photo-tune Ca2+-dependent gene expression, and modulate a myriad of Ca2+-dependent activities
in cells of the immune system, including effector T cell activation, macrophage-mediated inflamma-
some activation, dendritic cells (DC) maturation and antigen presentation. Our study set the stage
for achieving the goal of remote optogenetic immunomodulation and spatiotemporal control over
cellular immunotherapy in a wireless manner.
Results
Following antigen presentation, T cell receptor (TCR) engagement triggers a cascade of signaling
events in T lymphocytes that elicit the influx of extracellular Ca2+ through the CRAC channel, a clas-
sic example of store operated Ca2+ entry (SOCE) (Hogan et al., 2010; Prakriya and Lewis, 2015).
The molecular choreography of SOCE is mainly coordinated by two proteins that are located in dis-
tinct cellular compartments: (i) ORAI1, a four-pass transmembrane protein that constitutes the CRAC
channel pore-forming subunit in the plasma membrane (PM); and (ii) the stromal interaction mole-
cule 1 (STIM1), an ER-resident Ca2+ sensor protein that is responsible for sensing ER Ca2+ depletion
and directly gating ORAI1 channels through its cytosolic domain (STIM1-CT). Store depletion
induced Ca2+ influx through CRAC channels further activates calcineurin, a downstream Ca2+-depen-
dent phosphatase that dephosphorylates the master transcriptional regulator NFAT (nuclear factor
of activated T cells) and subsequently causes NFAT nuclear translocation (Mu¨ller and Rao, 2010). In
the presence of the co-stimulatory pathway, which activates the activator protein 1 (AP-1), NFAT
cooperates with AP-1 to turn on genes (e.g., IL-2 and IFN-g) that are characteristic of a productive
immune response (Mu¨ller and Rao, 2010). To enable light control over the Ca2+/NFAT pathway, we
set out to install light sensitivity into STIM1 by fusing a handful of STIM1-CT fragments with the
genetically-encoded photoswitch LOV2 (light, oxygen, voltage) domain (residues 404–546) of Avena
eLife digest Optogenetics is a technique that has been used to study nerve cells for several
years. It involves genetically engineering these cells to produce proteins from light-sensitive
bacteria, and results in nerve cells that will either send, or stop sending, nerve impulses when they
are exposed to a particular color of light. Neuroscientists have learned a lot about brain circuits
using the technique, and now researchers in many other fields are giving it a try.
There are, however, several challenges to using optogenetics in other types of cells. Nerve cells
create a tiny electrical impulses when they are activated, which helps them quickly transmit
messages. But other types of cells use more diverse means to communicate and transmit signals.
This means that optogenetics techniques must be adapted. Additionally, many cells are located
deep in the body and so getting the light to them can be difficult.
He, Zhang et al. have now developed an optogenetic system (termed “Opto-CRAC”) that can
control immune cells buried deep in tissue. The action of immune cells can be tuned by controlling
the flow of calcium ions through gate-like proteins in their membranes. He, Zhang et al. genetically
engineered immune cells so that a calcium gate-controlling protein became light sensitive. When the
cells were exposed to a blue light the calcium ion gates opened. When the light was turned off, the
gates closed. More intense light caused more calcium to enter into the cells. Further experiments
then revealed that exposing these engineered immune cells to blue light in the laboratory could
trigger an immune response.
The next obstacle was getting light to immune cells in a live animal. So, He, Zhang et al. used
specific nanoparticles that have been shown to help transmit light deep within tissue. In these
experiments, mice were injected with the light-sensitive immune cells and the nanoparticles. Then, a
near-infrared laser beam that can transmit into the tissues was pointed at the mice. This caused
calcium channels to open in the engineered cells deep in the mice. Finally, further experiments were
used to show that this light-based stimulation could boost an immune response to aid the killing of
cancer cells. Other scientists will likely use the technique to help them study immune, heart, and
other types of cells that use calcium to communicate.
DOI:10.7554/eLife.10024.002
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Figure 1. LOVSoc-mediated photoactivatable Ca2+ entry and nuclear translocation of NFAT in mammalian cells. (a), Schematic of light-operated Ca2+
entry though engineered Opto-CRAC channels. Fusion with the lightswitch LOV2 domain confers photosensitivity to the ORAI1-activating STIM1-CT
fragments. In the dark, STIM1-CT fragments are kept inactive presumably by docking toward the LOV2 domain. Upon blue light illumination, the
undocking and unfolding of the LOV2 C-terminal Ja helix lead to the exposure of the STIM1-CT fragments, enabling their interaction with ORAI1 Ca2+
channels to trigger Ca2+ influx across the plasma membrane. See Figure 1—figure supplement 1 for the detailed design and comparison among the
designed Opto-CRAC constructs. (b), Light-inducible translocation of mCherry-LOV2404-546-STIM1336-486 (designated as mCh-LOVSoc) from the cytosol
to the plasma membrane in HEK293T-ORAI1 stable cells. Upper panel, the images represent the same cells in the dark (black bar) or exposed to blue
light at 470 nm (40 mW/mm2; blue bar). Scale bar, 10 mm. Lower panel, Kymograph of mCh-LOVSoc corresponding to the circled area (top) and
quantification of mCherry signals over three repeated light-dark cycles (bottom). n = 12 cells from three independent experiments. Error bars denote s.
e.m. (c), Light-induced Ca2+ influx reported by the green genetically-encoded Ca2+ indicator (GECI) GCaMP6s. The global cytosolic Ca2+ change was
monitored after cotransfection of mCh-LOVSoc and GCaMP6s in HeLa cells; whereas the local Ca2+ change near the PM was reported by the PM-
tethered GCaMP6s-CAAX construct. Shown were representative confocal or TIRF images following blue light stimulation (30 s, 40 mW/mm2). The photo-
activated Ca2+ response reflected in the fluorescence change was plotted on the right. n = 15 cells from three independent experiments. Error bars
denote s.e.m. Scale bar, 10 mm. (d), A representative example of light-inducible Ca2+ oscillation pattern generated by LOVSoc-expressing HeLa cells
Figure 1. continued on next page
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sativa phototropin 1 (Christie et al., 1999; Harper, 2003; Yao et al., 2008; Wu et al., 2009)
(Figure 1a and Figure 1—figure supplement 1). When expressed alone, these STIM1-CT fragments
are capable of eliciting varying degrees of constitutive activation of ORAI1 channels to mediate Ca2+
entry from the extracellular space to the cytosol (Yuan et al., 2009; Park et al., 2009; Zhou et al.,
2010a; Soboloff et al., 2012). In the dark, the C-terminal Ja helix docks to the LOV2 domain
(Harper, 2003; Yao et al., 2008; Wu et al., 2009) and keeps the ORAI1-activating STIM1-CT frag-
ments quiescent. Upon blue light illumination, photoexcitation generates a covalent adduct between
LOV2 residue C450 and the cofactor FMN (Figure 1—figure supplement 1d), thereby promoting
the undocking and unwinding of the Ja helix to expose the STIM1-CT fragments. Unleashed STIM1-
CT fragments further move toward the plasma membrane to directly engage and activate ORAI1
Ca2+ channels (Figure 1a,b).
We first created a series of Opto-CRAC constructs by varying the length of STIM1-CT fragments,
introducing mutations into the LOV2 domain and optimizing the linker between these two moieties
(Figure 1—figure supplement 1a). After an initial screen of approximately 100 constructs using
NFAT nuclear translocation and Ca2+ influx as readouts, we decided to use the LOV2-STIM1336-486
chimera (designated as ’LOVSoc’) in our following experiments because it showed no discernible
dark activity and exhibited the highest dynamic range in terms of evoking light-inducible Ca2+ influx
(Figure 1—figure supplement 1a,b). When expressed as an mCherry-tagged fusion protein in
HEK293-ORAI1 stable cells, LOVSoc underwent rapid translocation between the cytosol and the PM
in response to blue light illumination (t1/2,on = 6.8 ± 2.3 s; t1/2,off = 28.7 ± 6.5 s; Figure 1b and
Video 1). This process could be readily reversed by switching the light off, and could be repeated
multiple times without significant loss in the magnitude of response. The light-dependent association
between LOVSoc and ORAI1 or ORAI1 C-terminus (ORAI1-CT) was further confirmed by a pulldown
assay using purified recombinant proteins and by coimmunoprecipitation assays (Figure 1—figure
supplement 2). In mammalian cells expressing LOVSoc, the degree of Ca2+ influx could be tuned by
varying the light power densities (Figure 1—figure supplement 3a). After photostimulation for
1 min with a power density of 40 mW/mm2 at 470 nm, LOVSoc triggered significant yet varied eleva-
tion of cytosolic Ca2+ concentrations to approximately 500–800 nM in a dozen of mammalian cell
types derived from various non-excitable tissues (Figure 1—figure supplement 3b), likely owing to
the varied endogenous levels of ORAI proteins among the tested cells. A Light-triggered global
Figure 1. Continued
when exposed to repeated light-dark cycles (30 s ON and 120 s OFF). The red Ca2+ sensor, R-GECO1.2, enabled recording of the whole course of
intracellular Ca2+ fluctuation. n = 8 cells from three independent experiments. Blue bar indicates light stimulation at 470 nm with a power density of 40
mW/mm2. Error bars denote s.e.m. (e), Photo-triggered current-voltage relationships of CRAC currents in HEK293-ORAI1 cells transfected with mCh-
LOVSoc. mCherry positive cells were subjected to whole-cell patch-clamp by a ramp protocol ranging from -100 mV to 100 mV in the presence (blue) or
absence (gray) of light illumination. For the red curve, extracellular Na+ was replaced with a non-permeant ion NMDG+ to assess ion selectivity by
examining the contribution of Na+. (f), Light-tunable nuclear translocation of GFP-NFAT1 and NFAT-dependent luciferase (NFAT-Luc) gene expression
in HeLa cells transfected with mCh-LOVSoc. The HeLa-GFP-NFAT1 stable cells were subjected to light pulse stimulation for 30 s whilst the interpulse
intervals were varied from 0.5 to 4 min. Representative snapshots of cells during GFP-NFAT1 nuclear translocation were shown in the middle panel. The
corresponding time courses and dependence of NFAT nuclear translocation or NFAT-Luc activity on the interpulse interval were plotted on the right. n
= 15–20 cells from three independent experiments. Error bars denote s.e.m. Scale bar, 10 mm.
DOI: 10.7554/eLife.10024.003
The following figure supplements are available for Figure 1:
Figure supplement 1. Design and characterization of engineered Opto-CRAC constructs (related to Figure 1a).
DOI: 10.7554/eLife.10024.004
Figure supplement 2. Light-dependent interaction between LOVSoc and ORAI1 (related to Figure 1b).
DOI: 10.7554/eLife.10024.005
Figure supplement 3. Characterization of photoactivatable Ca2+ entry into mammalian cells (related to Figure 1c,d).
DOI: 10.7554/eLife.10024.006
Figure supplement 4. Global and local Ca2+ influx generated by photo-activation of LOVSoc at defined spatial resolution (related to Figure 1c).
DOI: 10.7554/eLife.10024.007
Figure supplement 5. Schematic representation and light-induced response curves of Opto-CRAC variants reported by GCaMP6s.
DOI: 10.7554/eLife.10024.008
Figure supplement 6. Examples of light-tunable Ca2+ oscillation patterns generated in HeLa cells (related to Figure 1d).
DOI: 10.7554/eLife.10024.009
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Ca2+ influx and oscillations in HeLa or HEK293T cells expressing mCherry-LOVSoc could be moni-
tored in real-time by either Fura-2 (Figure 1—figure supplement 3c) or genetically-encoded Ca2+
indicators (GECIs), including GCaMP6 (Figure 1c and Videos 2,3) (Chen et al., 2013), R-CaMP2
(Figure 1—figure supplement 3d) (Inoue et al., 2015), and R-GECO1.2 (Figure 1d and Figure 1—
figure supplement 3e) (Wu et al., 2013). Notably, localized light stimulation can be applied to
achieve local activation of Ca2+ influx at a defined spatial resolution (Figure 1—figure supplement
4 and Video 4), thereby providing a new approach to dissect the effect of Ca2+ microdomains in var-
ious biological processes (Parekh, 2008). Depending on the kinetic properties of the Ca2+ indicators
used, the half-life time of the cytosolic Ca2+ rise in response to light stimulation ranged from 23 s to
36 s. After switching off the light, the cytosolic Ca2+ signal decayed with a half-life time of approxi-
mately 25–35 s (Figure 1—figure supplement 3f). These values are largely in agreement with the
time scale of SOCE under physiological stimulation (Hogan et al., 2010; Prakriya and Lewis, 2015;
Soboloff et al., 2012). We further measured the photo-activated currents by whole-cell recording in
HEK293 cells stably expressing ORAI1 (Figure 1e). Following light stimulation, HEK293 cell trans-
fected with LOVSoc developed a typical inward rectifying current, which is characteristic of the
CRAC channel and distinct from the greater outward currents of non-selective cation channels such
as TRPC (Prakriya and Lewis, 2015). Substitution of the most abundant extracellular cation Na+ by
a non-permeant ion NMDG+ did not alter the amplitude or overall shape of the CRAC current,
implying that Na+ has negligible contribution to LOVSoc- mediated photoactivatable Ca2+-selective
CRAC currents.
To confer more flexibility to the Opto-CRAC system with varied optical sensitivity, we explored
the use of co-expression, membrane tethering or fusion strategies to generate five more variants of
Opto-CRAC (Figure 1—figure supplement 5). We used either an internal ribosome entry site
(IRES)-based bicistronic vector or a self-cleaving 2A peptide strategy (de Felipe et al., 2006) to
enable the coexpression of ORAI1 and LOVSoc in the same cell with a single vector. Compared to
LOVSoc alone, both co-expression systems resulted in ~1.4-fold increase in Ca2+ response (Fig-
ure 1—figure supplement 5a). Tethering LOVSoc to the plasma membrane (PM) with an N-terminal
PM-targeting sequence derived from the Src kinase Lyn (Inoue et al., 2005) (Lyn11-LOVSoc) expe-
dited the photoactivation process by 3.5-fold (Figure 1—figure supplement 5b), presumably owing
to its increased local concentration and much closer proximity to the ORAI1 channels. By contrast, a
concatemeric form of LOVSoc with two copies covalently connected in a single polypeptide or its
fusion to ORAI1 substantially slowed down photoactivatable Ca2+ influx (Figure 1—figure supple-
ment 5c). Collectively, we have created a set of Opto-CRAC constructs that meet the varying needs
on sensitivity and photoactivation kinetics (Figure 1—figure supplement 5d,e).
We next asked if we could manipulate the light pulse to generate diverse temporal patterns of
Ca2+ signals to tune the degree of NFAT activation, which would be reflected in the efficiency of
NFAT nuclear translocation and NFAT-depen-
dent luciferase expression. We applied a fixed
Video 1. Light-triggered reversible cytosol-to-PM
translocation of mCh-LOVSoc. Three dark-light cycles
were applied to HEK293-ORAI1 stable cells transfected
with the Opto-CRAC construct mCh-LOVSoc.
DOI: 10.7554/eLife.10024.010
Video 2. Time-lapse imaging of light-triggered Ca2+
influx reported by cytosolic (left) or PM-tethered
GCaMP6s. HeLa cells expressing mCh-LOVSoc was
exposed to a 488-nm confocal laser.
DOI: 10.7554/eLife.10024.011
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light pulse of 30 s while varying the interpulse
intervals from 0.5 to 4 min to generate Ca2+
oscillation patterns with defined temporal reso-
lution (Figure 1d and Figure 1—figure supple-
ment 6) and compared the levels of NFAT
activation in HeLa cells. As shown in Figure 1f
prolonged interpulse interval was largely accom-
panied by a decrease in the nuclear accumula-
tion of NFAT. This observation agrees well with
previous reports showing that higher Ca2+ oscil-
lation frequencies, or faster repetitive Ca2+
pulses, tend to increase the ability to activate
NFAT (Lewis et al., 1998). Thus, we have dem-
onstrated that the engineered Opto-CRAC tools
are able to achieve remote and photo-tunable
activation of NFAT in mammalian cells
(Figure 1f and Video 5). We further confirmed
the NFAT-dependent gene expression in HeLa
cells transfected with an NFAT-driven luciferase
(NFAT-Luc) reporter construct. In the presence
of the co-stimulatory pathway (mimicked by the
addition of the pleiotropic PKC activator PMA), light illumination led to a robust increase in lucifer-
ase gene expression (Figure 2a). A decrease in the light pulse frequency also caused a reduction in
the efficiency of Ca2+/NFAT-driven luciferase expression (Figure 1f). To obviate the use of carcino-
genic PMA to photo-trigger gene expression, we also introduced a synthetic 5’ transcription regula-
tory region upstream of gene Ins1 (Stanley et al., 2012), which contains a furin cleavage site that
allows insulin processing in non-beta cells such as HEK293 cells (Shifrin et al., 2001). The 5’ region
is composed of three Ca2+-responsive elements
in cis, including 2–3 copies of serum response
elements (SRE), cAMP response elements (CRE)
and NFAT response elements with a minimal
promoter. Upon light stimulation, we observed a
robust production of insulin in cells transfected
with LOVSoc, but not in those without LOVSoc
expression (Figure 2a).
In order to confirm light-inducible gene
expression in a more physiologically relevant sys-
tem, we retrovirally transduced the mCherry-
tagged LOVSoc construct into naı¨ve CD4+ T
cells isolated from mice (Figure 2b and Fig-
ure 2—figure supplement 1). We then com-
pared the expression levels of two signature
genes that are characteristic of activated CD4+ T
cells (IL-2 and IFN-g ), in the presence or absence
of light illumination, using qRT-PCR and ELISA
(Figure 2b). Again, in the presence of PMA, light
stimulation faithfully mimicked ionomycin-
induced effects on the Ca2+/NFAT pathway and
remarkably boosted the cytokine production by
over 15–30 fold in CD4+ T cells transduced with
mCh-LOVSoc. By contrast, control cells trans-
duced with the mock retrovirus failed to exhibit
light-dependent production of cytokines (Fig-
ure 2—figure supplement 1). In addition to its
well-established role in driving effector T cell
activation, intracellular Ca2+ immobilization in
Video 3. Light-inducible Ca2+ influx monitored with
TIRF microscopy in HeLa cells coexpressing GCaMP6s-
CAAX and mCh-LOVSoc.
DOI: 10.7554/eLife.10024.012
Video 4. Sequential and localized activation of Ca2+
influx with defined spatial resolution. Imaging was
performed on HeLa cells cotranfected with mCh-
LOVSoc and GCaMP6s-CAAX. The boxed area was
subjected to a brief photostimulation with the 488-nm
laser for 10 s, followed by photoexcitation of the whole
field at 488 nm to acquire GCaMP6s-CAAX signals. The
boxed area showed preactivation of Ca2+ influx as
reflected by the strong fluorescence signal at time
point 0 s; whilst the other areas exhibited a gradual
increase in fluorescence intensity following 488-nm
light illumination.
DOI: 10.7554/eLife.10024.013
He et al. eLife 2015;4:e10024. DOI: 10.7554/eLife.10024 6 of 25
Tools and resources Biochemistry Cell biology
Figure 2. Photo-manipulation of Ca2+-dependent gene expression and immune response. All data were shown as mean  s.d. from three independent
experiments. *P<0.05; **P<0.01; ***P<0.001 (paired Student’s t-test). (a), Light-triggered Ca2+-dependent gene expression. Cells were either kept in the
dark or exposed to pulsed blue light (30 s on with 30 s interval; 40 mW/mm2) for 6 hr prior to cell lysis to quantify luciferase activity (middle) or insulin
production (right). Iono, ionomycin. PMA, phorbol 12-myristate 13-acetate. Left panel, Schematic of experimental design. Three upstream Ca2+-
responsive elements in the 5’ transcription regulatory region enable efficient initiation of gene expression of the downstream Ins1 gene encoding
insulin following LOVSoc-mediated photoactivatable Ca2+ entry and NFAT nuclear translocation. SRE, serum-response element; CRE, cyclic adenosine
monophosphate response element; NFAT RE, nuclear factor of activated T cells response element. Middle panel, Ca2+/NFAT-dependent luciferase
activity in HeLa cells transfected with LOVSoc and an NFAT-dependent firefly luciferase reporter vector. A third plasmid encoding the Renilla luciferase
gene was cotransfected as a reference gene for normalization of gene expression. Right panel, Photo-inducible insulin production driven by Ca2+-
responsive elements in HEK293T cells. (b), Photo-inducible expression of IL-2 and IFN-g genes in mouse CD4+ T cells expressing the LOVSoc construct.
Mouse CD4+ T cells were enriched and purified using an immunomagnetic negative selection kit and transduced with a retrovirus encoding mCh-
LOVSoc. On day 5 after transduction and expansion in the presence of IL-2, cells were treated with or without PMA, shielded from light or illuminated
with blue light for 8 hr, and then lysed for qPCR (upper panels) or ELISA analyses (lower panels). The schematic of the experiment was shown on the
left. Upper panel, Optogenetic stimulation of cytokine production in mouse CD4+ effector T cells transduced with a retrovirus encoding mCh-LOVSoc.
Right panel, Cytokine production (IL-2 and IFN-g that are characteristic of activated CD4+ T cells) was determined by ELISA. (c), Photo-tunable
amplification of inflammasome activation in macrophages. Human THP-1-derived macrophages were transduced with lentiviruses expressing mCh-
Figure 2. continued on next page
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macrophage is critical for the activation of the NLRP3 (nucleotide-binding domain, leucine-rich-
repeat-containing family, pyrin domain-containing 3) inflammasome (Murakami et al., 2012;
Lee et al., 2012; Horng, 2014), which is accompanied by the release of processed caspase-1 (p20
subunit) and the proinflammatory cytokine IL-1b into culture supernatants (Figure 2c). Following
photostimulation at 5 or 50 mW/mm2, we observed a notable light intensity-dependent boost in the
production of IL-1b and processed caspase -1 (p20 subunit) in lipopolysaccharide (LPS)-primed
THP1-derived macrophages in the presence of a commonly used inflammasome inducer nigericin
(Figure 2c), thus confirming the feasibility of harnessing the power of light to amplify macrophage-
mediated inflammatory responses ex vivo. In aggregate, light-induced activation of the Opto-CRAC
channel can generate both global and local Ca2+ signals and subsequently cause hallmark physiolog-
ical responses in both model cellular systems (e.g., HeLa or HEK293 cells) and rodent or human cells
of the immune system.
One fundamental roadblock that hampers the application of optogenetic tools in vivo is their
inability to stimulate deep within tissues without the use of invasive indwelling fiber optic probes. In
order to seek the possibility of controlling the Ca2+/NFAT pathway using light in the deep tissue
penetrating near-infrared range, we explored the use of lanthanide-doped upconversion nanopar-
ticles (UCNPs) as the NIR light transducer (Sun et al., 2015; Gnach et al., 2015; Wu et al., 2015).
Our UCNPs proved to be highly photostable, and their unique upconversion (NIR excitation and
emission at visible light range) properties make them an ideal for the remote photoactivation of
Opto-CRAC channel activities (Wu et al., 2009;
Ostrowski et al., 2012). In order to match the
absorption window of LOV2, we chose mono-
dispersed 40-nm b-NaYF4: Yb, Tm@b-NaYF4
UCNPs (Figure 3—figure supplement 1) that
exhibit bright blue emission upon 980 nm CW
laser irradiation. When excited at 980 nm, the
synthesized UCNPs displayed a sharp emission
peak centered around 470 nm (Figure 3a). Like
direct blue light illumination, UCNPs were able
to cause photoactivation of recombinant LOV2
proteins, as reflected by the absorbance
changes following NIR light stimulation and the
subsequent recovery to the dark state
(Figure 3b). This finding clearly validates the fea-
sibility of shifting the spectral sensitivity toward
the NIR window to activate LOV2-based optoge-
netic tools.
In order to effectively and specifically illumi-
nate the LOV2-based optogenetic construct in a
cellular context, we first developed streptavidin-
conjugated UCNPs, then engineered a geneti-
cally-encoded streptavidin-binding tag (Strep-
Tag) into the second extracellular loop of the
ORAI1 Ca2+ channel (mCh-ORAI1StrepTag,
Video 5. Light-inducible nuclear translocation of NFAT
in HeLa cells. The HeLa GFP-NFAT stable cell line was
transiently transfected with mCh-LOVSoc and exposed
to pulsed light stimulation at 470 nm (30 s for every 1
min). Shown were fluorescence signals from the green
(GFP-NFAT, left panel) and red (mCh-LOVSoc, right
panel) channels in the same field. Only cells expressing
the Opto-CRAC construct (mCherry-positive, lower
right corner) showed light-dependent NFAT nuclear
translocation. Note that the cytosol-to-PM translocation
of mCh-LOVSoc is not evident as in Video 1 due to the
low expression level of endogenous ORAI1 in HeLa
cells and much more abundant expression of mCh-
LOVSoc. Nonetheless, the light-triggered activation of
endogenous ORAI1 channel was sufficient to activate
the downstream GFP-NFAT nuclear translocation.
DOI: 10.7554/eLife.10024.016
Figure 2. Continued
LOVSoc, primed with LPS (100 ng/ml) and incubated with inflammasome inducer nigericin (10 mM) for 6 hr. Cells were either shielded from light or
illuminated with pulsed blue light for 8 hr at power densities of 5 or 40 mW/mm2. The cell lysates were collected for ELISA analysis (left) and WB (right).
The schematic of the experiment was shown on the left. Left panel, the amount of secreted IL-1b in the culture supernatant quantified by ELISA. Right
panel, NLRP3 inflammasome activation assessed by Western blotting of lysates and supernatants harvested from cells treated with indicated conditions.
Arrowhead, processed caspase 1 (Casp-1) subunit p20.
DOI: 10.7554/eLife.10024.014
The following figure supplements are available for Figure 2:
Figure supplement 1. Retroviral transduction of CD4+ T cells and control experiments (related to Figure 2b).
DOI: 10.7554/eLife.10024.015
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Figure 3. NIR light control of Opto-CRAC by lanthanide-doped upconversion nanoparticles. (a), Physiochemical
properties of the synthesized upconversion nanoparticles. Upper panel, schematic illustration of the core/shell
structure and energy transfer (ET) among lanthanide ions in the NaYF4: Yb, Tm@NaYF4 upconversion nanoparticles
(UCNPs). Lower panel, the emission spectrum of NaYF4: Yb, Tm@NaYF4 (solid red line) upon 980 nm CW laser
irradiation (15 mW/mm2) superimposed by the absorbance spectrum of recombinant LOV2 protein (dashed blue
line). Inset: the bright blue emission could efficiently lighten the background upon NIR light illumination at 980
nm. (b), NIR light-induced changes in the absorption spectra of purified MBP-LOVSoc at different time interval
after mixing with UCNPs-Stv and irradiation with a 980 nm laser (1 min at a power density of 30 mW/mm2). After
blue (excited at 470 nm as control, blue circle) or NIR (red triangle) light stimulation, the recovery time course of
LOV2 absorbance at 450 nm was plotted in the lower panel. (c), Specific targeting of streptavidin-conjugated
UCNPs to engineered ORAI1 channels in the plasma membrane of HeLa cells. Left panel, Schematic showing the
interaction between streptavidin-coated upconversion nanoparticles (UCNPs-Stv) and the engineered ORAI1 Ca2+
channel that harbors a streptavidin-binding tag (StrepTag) in the second extracellular loop. The mCh-
ORAI1StrepTag protein was able to efficiently recruit and anchor UCNPs-Stv to the plasma membrane of transfected
Figure 3. continued on next page
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Figure 3c) and assessed its capability to recruit streptavidin-conjugated UCNPs (UCNPs-Stv, Fig-
ure 3—figure supplement 1). In HeLa cells expressing mCh-ORAI1-StrepTag, we detected remark-
able local accumulation of UCNPs-Stv on the plasma membrane (Figure 3c), confirming the cell-
specific targeting of functionalized nanoparticles. To examine whether UCNPs-transduced blue light
is sufficient to trigger the opening of Opto-CRAC channels, we monitored cytosolic Ca2+ changes
using GCaMP6s in HeLa cells co-expressing LOVSoc, mCh-ORAI1-StrepTag and GCaMP6s following
NIR light stimulation (980 nm). Within 20 s, transfected HeLa cells exhibited a significant increase in
GCaMP6s fluorescence, indicating a rapid rise in the intracellular Ca2+ concentration that was
evoked by NIR light (Figure 3d). This was further confirmed by using a red-emitting Ca2+ indicator
R-GECO1.2, which enabled recording of reversible Ca2+ fluctuation cycles and circumvented the
complications associated with potential direct activation of LOVSoc by the green light source used
to excite GCaMP6 signals (Figure 3e). This increase was found to be caused by Ca2+ influx through
NIR-to-blue activated Opto-CRAC channels because cells incubated with the control NIR-to-green
UCNPs (b-NaYF4: Yb, 2% Er @ b-NaYF4; emission maxima at 510 nm) did not show discernible
changes in the GCaMP6s signal upon stimulation with the same NIR light (Figure 3—figure supple-
ment 2). We then employed NIR light to remotely activate the downstream effector NFAT at the cel-
lular level, and observed NFAT nuclear translocation (Figure 3d), as well as NFAT-dependent IFN-g
production in CD4+ T lymphocytes (Figure 3f). Next, we sought to demonstrate the potential appli-
cation of NIR-triggered activation of the Opto-CRAC system in vivo. We performed a proof-of-princi-
ple experiment by implanting NFAT-Luc/LOVSoc expressing HeLa cells pre-incubated with UCNPs-
Stv subcutaneously in the flanks of mice. The implanted site was irradiated by a 980-nm CW laser
Figure 3. Continued
HeLa cells. Right panel, Florescence microscopy imaging showing the accumulation of UCNPs-Stv (green, lex: 980
nm, lem: 450–500 nm) on the plasma membrane of cells transfected with mCh-ORAI1-StrepTag. Scale bar, 10 mm.
(d), NIR light-triggered Ca2+ influx and NFAT nuclear translocation in HeLa cells coexpressing mCh-ORAI1StrepTag
and LOVSoc. Ca2+ influx was monitored by GCaMP6s fluorescence whilst GFP-NFAT translocation was reported
by GFP signals. Transfected cells were mixed with UCNPs-Stv (20 mg/ml) and illuminated by a 980-nm CW laser to
trigger the Ca2+ influx. The relatively slow onset of Ca2+ influx and NFAT nuclear translocation provided us a time
window to quickly capture the green signals without noticeably activating LOVSoc during image acquisition at low
excitation energy (<1 mW/mm2). Scale bar, 10 mm. (e), NIR light-induced reversible Ca2+ influx reported by R-
GECO1.2. HeLa cells were transfected with an IRES bicistronic pMIG retroviral construct that enabled coexpression
of ORAI1StrepTag and mCh-LOVSoc. Transfected cells were mixed with 5 mg UCNPs-Stv and illuminated by a 980-
nm laser at 30 mW/mm2 to trigger the Ca2+ influx. Data were shown as mean ± s.e.m. from 12 cells in two
independent experiments. (f), Flow cytometry analysis of IFN-g production in mouse CD4+ T lymphocytes
transduced with retroviruses co-expressing mCh-LOVSoc and ORAI1StrepTag. Freshly isolated CD4+ T cells were
subjected to in vitro differentiation as described in Figure 2b, incubated with 20 mg/ml UCNPs-Stv and 1 mM PMA,
and exposed to overnight NIR light pulse (ON/OFF interval of 30 s, 980 nm, 30 mW/mm2) prior to analysis. (g),
NFAT-dependent luciferase expression in vivo triggered by NIR light stimulation. Left, Schematic of experimental
setup. HeLa cells were transfected with NFAT-Luc and constructs encoding LOVSoc/ORAI1StrepTag. 48 hr post-
transfection, cells were treated with 1 mM PMA, incubated with 10 mg UCNPs-Stv (blue sphere) and implanted to
the flanks of mice subcutaneously. The implanted areas were then subjected to NIR light irradiation (red) with a
980 nm CW laser (50 mW/mm2, 30 sec ON, 30 sec OFF for a total of 25 min). Right, Shown were bioluminescence
imaging of three representative BALB/c mice, one implanted with HeLa cells expressing NFAT-Luc only (left) and
the other two with cells expressing LOVSoc and NFAT-Luc (middle and right). Mice were subjected to NIR light
irradiation (left and right) with a 980 nm CW laser. The images were acquired 20 min after receiving a single dose
of luciferin (100 mL, 15 mg/ml, s.c.). Luciferase-catalyzed bioluminescence was visualized as false color with the
same rainbow scale bar for all acquired images. Red circle, implanted area.
DOI: 10.7554/eLife.10024.017
The following figure supplements are available for Figure 3:
Figure supplement 1. Synthesis scheme and in vitro characterization of UCNPs.
DOI: 10.7554/eLife.10024.018
Figure supplement 2. Green-emitting UCNPs did not activate Opto-CRAC channels upon NIR light stimulation
(related to Figure 3d).
DOI: 10.7554/eLife.10024.019
Figure supplement 3. No noticeable heat generation during the in vivo experiment.
DOI: 10.7554/eLife.10024.020
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outside the body (Figure 3e) without noticeable heat production (Figure 3—figure supplement 3a,
b) or severe damage to local tissues (Figure 3—figure supplement 3c). Luciferase-catalyzed biolu-
minescence was readily detected after NIR irradiation, whereas no discernible background activation
was observed in the negative controls where LOVSoc expression and/or NIR light were absent
(Figure 3g).
To explore the application of the NIR Opto-CRAC system in a more disease-relevant context, we
set out to combine the use of our optogenetic system with DC-mediated immunotherapy in the
B16-OVA mouse model of melanoma (Briles and Kornfeld, 1978; Fidler, 1975), in which ovalbumin
(OVA) (Falo et al., 1995; Mayordomo et al., 1995) is used as a surrogate tumor antigen
(Figure 4a). Dendritic cells, which provide the essential link between the innate and adaptive
immune responses, are adept at capturing tumor antigens and cross-presenting these antigens to T
cells in tumor draining lymph nodes (dLNs), thereby sensitizing and generating tumor-specific cyto-
toxic lymphocytes (CTLs) to cause tumor regression or rejection (Palucka and Banchereau, 2012).
One of the major challenges of DC vaccination-based immunotherapy is how to efficiently maintain
the maturational status of DCs. Pharmacological agents (e.g., ionomycin) or signaling pathways con-
trolling intracellular Ca2+ mobilization have been reported to facilitate immature dendritic cell matu-
ration through up-regulation of co-stimulatory molecules CD80 or CD86, major histocompatibility
complex (MHC) class I and class II, as well as the chemokine receptor CCR7 (Fe´lix et al., 2013;
Matzner et al., 2008; Hsu et al., 2001; Koski et al., 1999; Czerniecki, 1997). We hypothesize that
photoactivatable Ca2+ influx in DCs will lead to similar phenotypic changes to expedite and sustain
DC maturation and promote antigen presentation, thereby maximally sensitizing T lymphocytes
toward tumor antigens to boost anti-tumor immune response. To quickly test this in vitro, we trans-
duced bone marrow-derived DCs (BMDCs) with retroviruses encoding both LOVSoc and ORAI1Strep-
Tag (termed ’Opto-CRAC DCs’), pulsed cells with a mixture of OVAp (257SIINFEKL264) and UCNPs-Stv
nanoparticles. NIR light stimulation resulted in approximately 2–8 fold increase in the surface expres-
sion of MHC-I/II, CD86, and CCR7 (Figure 4b), which are characteristic of matured DCs that are
capable of homing to dLNs to interact with T cells to modulate adaptive immune response
(Palucka and Banchereau, 2012). We next used ex vivo cross-presentation assay to examine how
CD8 T cells from OT-1 Rag1-/- mice respond to the OVA antigen presented by DCs. The isolated
OT-1 CD8 T cells, bearing transgenic T cell receptors that specifically recognize processed OVA
peptides (Clarke et al., 2000; Hogquist et al., 1994), were co-cultured with Opto-CRAC DCs in the
presence of OVAp and UCNPs-Stv. After NIR stimulation, co-cultured OT-1 CD8 T cells exhibited
over 2-fold increase in both proliferation (Figure 4c) and IFN-g release (Figure 4d), clearly attesting
to the feasibility of using the NIR-stimulable Opto-CRAC system to expand and photo-prime anti-
gen-specific T cells.
To further validate the immunomodulatory function in vivo, we injected UCNPs-Stv/OVA loaded
Opto-CRAC DCs to the B16-OVA murine model of melanoma (Falo et al., 1995;
Mayordomo et al., 1995), in which the B16 tumor cells bearing the OVA antigen could be readily
recognized by OT-1 CD8 T cells to elicit anti-tumor immune responses (Matzner et al., 2008;
Hsu et al., 2001). We next adoptively transferred CFSE-abled, OVA-specific OT-I CD8 T cells into
the B16-OVA mice and examined their in vivo activation and phenotypic profiles following photoacti-
vatable DC maturation. Compared to the control group shielded from NIR, the proliferation of
CD8 T cells was substantially up-regulated after light stimulation, by judging from decreased CFSE
staining due to proliferative dilution and increased population of OT-1 CD8T cells in tumor draining
LNs and spleens (Figure 4e). To assess the functional consequence of immunosensitization of tumor
cells toward Opto-CRAC DC-activated immune response, we monitored the tumor growth in mouse
melanoma models generated by either subcutaneous or i.v. injection of B16-OVA melanoma cells
(Figure 4a). NIR light stimulation significantly suppressed the tumor growth with diminished tumor
volume (Figure 4f) or reduced numbers of tumor foci in the lungs (Figure 4g). Both our ex vivo and
in vivo data converge to support the conclusion that NIR-stimulable Opto-CRAC DC can robustly
enhance tumor cell susceptibility to CTL-mediated killing, thereby improving antigen-specific
immune responses to selectively destruct tumor cells. By acting as a genetically-encoded ’photoacti-
vatable adjuvant’, the Opto-CRAC system may hold high potential for its future use in cancer
immunotherapy.
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Figure 4. NIR light control of Opto-CRAC DC-mediated antigen cross-presentation to OT-I CD8 T cells and B16-OVA melanoma killing. Data were
shown as mean  s.e.m. from at least three independent experiments. *p<0.05; **p<0.01; ***p<0.001 (paired Student’s t-test). (a), Scheme showing the
experimental design. NIR-stimulated Ca2+ influx in Opto-CRAC DCs prompts immature DC maturation and OVA antigen cross-presentation to activate
and boost anti-tumor immune responses mediated by OT-1 CD8 T cells (cytotoxic T lymphocytes, CTLs), thereby sensitizing tumor cells to OVA-
specific, CTL-mediated killing in the B16-OVA melanoma model. OVA peptide (OVAp, 257SIINFEKL264) is used here as a surrogate tumor antigen.
Rag1-/- mice were subcutaneously (s.c.) implanted in the flank or intravenously (i.v.) injected with 2 x 106 B16-OVA tumor cells per mice to induce
melanoma and lung metastasis. Bone marrow-derived dendritic cells (BMDCs) expressing the Opto-CRAC system (Opto-CRAC DCs) were pulsed with
UCNPs-Stv and OVA257-264 peptides and injected into Rag1
-/- mice 3 days after tumor cell injection. Sorted OT-I CD8 cells from OT-I Rag1-/- mice,
which are labeled by CSFE for monitoring DC antigen cross-presentation and T cell proliferation in vivo, were transferred into B16 tumor-bearing mice
one day after Opto-CRAC DC infusion. Mice were kept in dark or exposed to NIR for 1 week (8 hr per day, 1 min ON/OFF pulse, 30 mW/mm2) after DC
injection to stimulate Opto-CRAC DC maturation in vivo and photo-boost tumor antigen cross-presentation. 5 days after adoptive transfer, tumor
draining lymph nodes (dLNs) and spleen were harvest for FACS (panel e) analysis on CFSE-labeled CD8 T cells. Tumor growth was measured by caliper
(panel f) and mice were sacrificed on day 18 for lung metastasis analysis (panel g). (b), Flow cytometric analysis on the expression levels of MHC, co-
stimulatory and chemokine receptor molecules in BMDCs. Cells were double-immunolabeled with CD11c-FITC vs MHC class I-PE, CD86-PE, MHC class
Figure 4. continued on next page
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Discussion
In the present study, we described an NIR-stimulable optogenetic platform based on engineered
CRAC channels and lanthanide-doped upconversion nanoparticles. Depending on the pulse and
intensity of light input, the photosensitive module, LOVSoc, can reversibly generate both sustained
and oscillatory Ca2+ signals. The magnitude and kinetics of photo-activated Ca2+ influx largely mimic
the physiological responses following engagement of immunoreceptors or ligand binding to its cog-
nate membrane receptors that leads to store depletion (Prakriya and Lewis, 2015). Ectopic expres-
sion of a single component of LOVSoc at endogenous levels of ORAI is sufficient to elicit strong
intracellular Ca2+ elevation in a dozen of cell types derived from a wide range of human or rodent
tissues. Most critically, light-generated Ca2+ signals can further lead to hallmark physiological
responses in cells of the immune system. The sensitivity and photoactivation kinetics of this system
can be further tuned by tethering LOVSoc to PM or through co-expression and fusion with ORAI1.
When paired with deep tissue-penetrant and NIR-stimulable UCNPs, we have successfully demon-
strated the potential application of our Opto-CRAC system to drive Ca2+-dependent gene expres-
sion and to photo-modulate immune response both in vivo and ex vivo. Compared to other existing
optical tools, our Opto-CRAC system that has several distinctive features: First, complementary to
the existing ChR-based tools that exhibit less stringent ion selectivity and tend to perturb intracellu-
lar pH due to high proton permeability, our Opto-CRAC system is engineered from a bona fide Ca2+
channel that is regarded as one of the most Ca2+-selective ion channels. Although the unitary con-
ductance of CRAC channel is estimated to be low (<10 fS in 2 mM extracellular Ca2+ in T cells; com-
pared to 4–10 pS for voltage-gated Ca2+ channels) (Prakriya and Lewis, 2015; Zweifach and
Lewis, 1993), sustained Ca2+ influx (up to minutes) through native ORAI1 channels is sufficient to
activate downstream effectors. The high Ca2+ selectivity (PCa/PNa: >1000) and its small unitary con-
ductance is speculated to reduce the energy requirement of pumping out Na+ during sustained
Ca2+ entry, thereby enhancing the specificity of downstream effector function (Prakriya and Lewis,
2015). Second, the Opto-CRAC tool has a relatively small size (<900 bp, compared to >2.2 kb of
ChR) and is thus compatible with almost all existing viral vectors used for in vivo gene delivery.
Indeed, we have successfully used retroviral and lentiviral expression systems to deliver Opto-CRAC
into primary T cells, macrophages and dendritic cells. Its potential delivery into excitable tissues (e.
g., muscle, heart and brain) using adeno-associated viruses remains to be tested in follow-on studies.
Third, the tunable and relatively slow kinetics make it most suitable for interrogating Ca2+-modu-
lated functions in non-excitable cell types, such as cells in the endocrine, immune and hematopoietic
system. We find that our system may find broad use in adoptive cell transfer experiments or adop-
tive immunotherapies, which are widely used in both basic research and the clinic settings
(Palucka and Banchereau, 2012; Restifo et al., 2012). Fourth, in conjunction with upconversion
nano-transducers, the light harvesting window can be shifted to the NIR region where deep tissue
penetration and remote stimulation are feasible. Results from our in vivo studies clearly indicate that
the Opto-CRAC channel and its downstream effectors can be remotely activated using NIR light,
thereby paving the way for its future applications in more (patho)physiologically-relevant mouse
models, or ultimately, in cancer immunotherapies with improved spatiotemporal control over engi-
neered therapeutic T cells or DCs to reduce off-tumor cross-reaction and mitigate toxicity
(Morgan et al., 2010). Given the spatial and temporal accuracy of NIR light, it is also possible to use
Figure 4. Continued
II-APC or CCR7-PE and analyzed three days after viral transduction of Opto-CRAC. UCNPs-Stv/ OVA loaded Opto-CRAC DCs were exposed or
shielded from NIR illumination for 48 hr (30 mW/mm2 with 1 min pulse interval) prior to analysis. (c), Proliferation of sorted naı¨ve OT-I CD8 T cells co-
cultured with UCNPs-Stv/OVA loaded Opto-CRAC DCs, with or without NIR illumination, was measured by the [3H] thymidine incorporation assay. (d),
Flow cytometric analysis of IFN-g production in sorted naı¨ve OT-I CD8 T cells co-cultured with UCNPs-Stv/OVA loaded Opto-CRAC DCs with or without
NIR stimulation. (e), Flow cytometric analysis of in vivo proliferation of CFSE-APC labeled OT-I CD8 T cells in dLNs and spleen 6 days after injection of
UCNPs-Stv/OVA loaded Opto-CRAC DCs with or without NIR pulse excitation (30 mW/mm2) as indicated in panel a. (f), Tumor-inoculated sites (left)
were isolated from tumor-bearing mice (n = 5) shielded or exposed to NIR and the tumor sizes (mm3) were measured at indicated time points shown in
the growth curve (right) after tumor implantation. (g), Representative lungs with melanoma metastases (left) were isolated from tumor-bearing mice
shielded or exposed to NIR. The histogram represents counted numbers of visible pigmented tumor foci (as exemplified by the arrows) with pulmonary
melanoma metastases on the surface of lungs (right panel; n = 5 mice).
DOI: 10.7554/eLife.10024.021
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guided NIR light to confine localized blue light generation, thus avoiding the photoactivation of off-
target regions. Lastly, but critically, the lanthanide-doped UCNPs can be applied to activate other
optogenetic tools that are dependent on blue light-absorbing cofactors (e.g., ChR2 and CRY2). We
anticipate that the flexible adaptability of our novel approach will lead to new opportunities to fine-
tune Ca2+-dependent immune responses and interrogate other light-controllable cellular processes
while minimally interfering with the host’s physiology.
Materials and methods
Chemicals and antibodies
Fura-2 AM calcium indicator was purchased form Life Technologies (Carlsbad, CA, USA). Phorbol
12-myristate 12-acetate (PMA), ionomycin, thapsigargin (TG) and isopropyl-ginethiogalactopyrano-
side (IPTG) were purchased from Sigma Aldrich (St Louis, MO, USA). Tri(2-carboxyethyl)phosphine
(TCEP) was obtained from Pierce (Life Technologies). Amylose resin used for MBP pulldown was pur-
chased from New England Biolabs (Ipswich, MA, USA). Ni-NTA resin used for purification of GB1-
ORAI1-CT was purchased from Qiagen (Valencia, CA, USA). The mouse monoclonal anti-Flag M2-
HRP (A859, Sigma-Aldrich, St. Louis, MO, USA) antibody, the rabbit anti-mCherry polyclonal anti-
body (NBP2-25157, Novus Biologicals, Littleton, CO, USA), the rabbit anti-Caspase-1 antibody
(D7F10, Cell signaling, Danvers, MA, USA) and the rabbit anti-IL-1b antibody (sc-7884, Santa Cruz
Biotechnology, Dallas, TX, USA) were used at a 1:1000 dilution. For flow cytometry (FACS) analysis,
anti-mouse MHC Class II (I-A/I-E) APC (), anti-mouse IFN gamma PE (), anti-mouse CD86 (B7-2) PE
(12–7311), anti-mouse CD197 (CCR7) PE (12–1971), anti-mouse MHC Class I PE (12–9558), anti-
mouse CD11c FITC (11–0114), anti-mouse CD4 PerCP-Cyanine5.5 (45–0042), and anti-mouse CD8a
APC (17–0081) were purchased from eBioscience. All other reagents were form Sigma-Aldrich unless
otherwise indicated.
Plasmids
Constructs for fluorescence imaging and luciferase assays
The pTriEX-mcherry-PA-Rac1 plasmid was purchased from Addgene (#22027). STIM1-CT fragments
(residues 336–450, 336–460, 336–473, 336–486, 342–486, 344–486) were amplified using the KOD
hot start DNA polymerase (EMD Millipore, Billerica, MA, USA) and inserted downstream of LOV2404-
546 between HindIII-XhoI restriction sites to replace Rac1. The LOV2 fused STIM1233-450 construct
(LOVS1K) (Pham et al., 2011) was purchased from Addgene (#31981). The short linker (KL) between
LOV2 and STIM1-CT fragments was made by replacing Rac1 with STIM1336-486 in the vector pTriEx-
mcherry-PA-Rac1 using HindIII-XhoI sites; whilst the NotI-XhoI sites were used for producing a long
linker (KLAAA). Mutations in the LOV2 domain were introduced by using the QuikChange Lightning
Multi Site-Directed Mutagenesis Kit (Agilent Technologies, Santa Clara, CA, USA) by following the
manufacture’s protocol. pcDNA3.1-mCherry-ORAI1 were generated by sequential insertion of
mCherry in the BamHI-EcoRI sites and human ORAI1 gene between EcoRI and XhoI sites of the vec-
tor pCDNA3.1(+) (Life Technologies). Next, oligos encoding the StrepTag (WSHPQFEK)
(Schmidt and Skerra, 2007) were inserted into the second extracellular loop of ORAI1 after residue
208 through a standard PCR method to construct pcDNA3.1-mCherry-ORAI1-StrepTag. pGP-CMV-
GCaMP6s-CAAX (#52228), pGP-CMV-GCaMP6m (#40754) and CMV-R-GECO1.2 (#45494) were
obtained from Addgene. The firefly luciferase reporter vector pGL4.30[luc2P/NFAT-RE/Hygro]
(abbreviated as NFAT-Luc) and the control Renilla luciferase reporter plasmid pRL-TK were pur-
chased from Promega (Madison, WI, USA). The red calcium sensor pN1-R-CaMP2 was a gift from Dr.
Haruhiko Bito at University of Tokyo, Japan.
Constructs for co-expression of LOVSoc with ORAI1
A murine stem cell virus (MSCV)-based vector pMIG was obtained from addgene (#9044). This bicis-
tronic IRES-GFP containing retroviral was used for insertion of cDNA sequences encoding mCherry-
LOV2-STIM1336-486 between the XhoI and EcoRI restriction sites. The pMIG-mCh-LOVSoc plasmid,
along with the empty vector as control, was used for retroviral transduction of isolated mouse CD4+
T or dendritic cells. In a further modified version, GFP was replaced by cDNAs encoding WT or engi-
neered ORAI1 that contain a StrepTag in its second extracellular loop to recruit UCNPs-Stv, thus
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allowing bicistronic expression of both LOVSoc and ORAI1 in the same construct. To enable co-
expression at ~1:1 ratio, cDNAs encoding mCh-LOVSOC and ORAI1StrepTag were connected by a
self-cleaving 2A peptide sequence (de Felipe et al., 2006) and inserted into the pTriEx vector for
transient expression or into a LeGO lentiviral vector for transduction of human or rodent primary
cells.
Constructs for recombinant protein expression in E.Coli
The DNA sequences encoding LOVSoc described above were amplified and inserted into the vector
pMCSG9 between the BamHI and XhoI sites for expression as MBP-LOVSoc protein. To construct a
bacterial expression plasmid of ORAI1-CT (residues 259–301) fused with the B1 domain of strepto-
coccal protein G (GB1), the GB1 gene was inserted between NcoI-BamHI sites and ORAI1-CT was
subsequenlty inserted between the BamHI and XhoI sites of the host vector pProEx-HTb (Life Tech-
nologies). The GB1 tag was used as a small tag to enhance the protein solubility and aid affinity
purification.
Fluorescence Imaging and total internal reflection fluorescence (TIRF)
microscopy
HeLa, HEK293/HEK293T and other indicated immortalized cell lines from the American Type Culture
Collection (ATCC) were cultured in Dulbecco’s modified Eagle’s medium (DMEM, Sigma-Aldrich)
supplemented with 10 mM HEPES and 10% heat-inactivated fetal bovine serum. All the cells were
grown at 37˚C in a 5% CO2 atmosphere. Cultured cells were seeded on 35-mm glass bottom dishes
and an inverted Nikon Eclipse Ti-E microscope customized with Nikon A1R+ confocal laser sources
(405/488/561/640 nm) was used for confocal imaging. The same microscope body connected to a
Ti-TIRF E motorized illuminator unit (488 nm/20 mW and 561 nm/20 mW lasers) with a 60, NA 1.49
oil-immersion TIRF objective was used for TIRF imaging. 100-nm fluorescent beads (TetraSpeck
microspheres, Life Technologies) were deposited onto a coverslip and imaged as markers for later
alignment.
To monitor mCh-LOVSoc translocation from the cytosol to PM, 50–100 ng pTriEx-mCherry-LOV-
Soc was transfected to HEK293-ORAI1 stable cells using Lipofectamine 3000 (Life Technologies).
Cells were imaged 24 hr after transfection. Photostimulation was provided by an external blue light
(470 nm, tunable intensity of 0–50 mW/mm2, ThorLabs Inc., Newton, NJ, USA). Light power density
was measured by using an optical power meter from ThorLabs. Light cycles were applied either man-
ually or programmed by connecting to a DC2100 LED Driver with pulse modulation (ThorLabs).
Time-lapse imaging of mCherry signal was carried out in the dark by turning on only the 561-nm
laser channel.
For measurements of Ca2+ influx using the green color calcium indicator GCaMP6s, 50–100 ng
mCh-LOVSoc and 100 ng cytosolic GCaMP6s or membrane-tethered GCaMP6s-CAAX were cotrans-
fected into HeLa or HEK293T or other indicated cells using Lipofectamine 3000. Twenty-four hours
after transfection, a 488-nm laser was used to excite GFP, and a 561-nm laser to excite mCherry at
intervals of 1–5 s. The mCherry-positive cells were selected for statistical analysis. Since the excita-
tion wavelength used to acquire the GCaMP6s signals (488 nm) partially overlaps with the photo-
activating wavelength of LOVSoc, Ca2+ influx was elicited when the 488-nm laser source was turned
on, and thus GCaMP6s could only be used to monitor the ON phase of Ca2+ flux. For localized pho-
tostimulation, we took advantage of the NIKON component designed for fluorescence recovery
after photobleaching (FRAP) to stimulate selected areas (designated as pre-activated areas as exem-
plified in Figure 1—figure supplement 4 and Video 3) but only used 1–5% input of the 488-nm
laser for 5–10 s. Next, we recorded the GCaMP6s-CAAX signals in the whole field.
For measurements of Ca2+ influx using the red-emitting Ca2+ sensor (R-GECO1.2 or R-CaMP2), a
total of 300 ng DNA (100 ng mCh-LOVSoc and 200 ng Ca2+ sensor) was transfected into HeLa or
HEK293 T cells. The 561-nm laser source as used to excite red emission with blue light stimulation
imposed as described above. Because the 561-nm laser cannot activate LOVSoc, both the ON and
OFF phases of Ca2+ fluctuation can be monitored by applying multiple dark-light cycles with an
external pulsed LED light (470 nm at power intensity of 40 mW/mm2) or using the 488-nm laser
source from the Nikon A1R+ confocal microscope.
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To monitor light-inducible NFAT nuclear translocation, we used a HeLa cell line stably expressing
NFAT11-460-GFP. mCh-LOVSoc was transfected into this stable HeLa cell line and cells were imaged
24 hr posttransfection. A fixed blue light pulse of 30 s (40 mW/mm2) was applied to the transfected
cells with the interpulse interval varying from 0.5, 1, 4, to 8 min. A total of 24 min time-lapse images
were recorded and the GFP signal ratio (nuclear vs total GFP) was used to report the efficiency of
NFAT activation. At least 15 cells were analyzed for each condition in three independent
experiments.
Intracellular Ca2+ measurements with Fura-2 were performed using our previous protocols
(Wang, 2014; Zhou et al., 2010a; 2010b; 2013). Briefly, one day before imaging, HEK293 cells tran-
siently expressing mCh-LOVSoc were seeded and cultured on cover slips. To load Fura-2 AM, cells
were kept in the imaging solution with 0 mM CaCl2 and 2 mM Fura-2 AM for one hour. The imaging
solution consists of (mM) 107 NaCl, 7.2 KCl, 1.2 MgCl2, 11.5 glucose, 20 HEPES-NaOH (pH 7.2), and
0 or 1 mM CaCl2. Fura-2 signals were then obtained using a ZEISS oberserver-A1 microscope
equipped with a Lambda DG4 light source (Sutter Instruments), Brightline FURA2-C-000 filter set
(Semrock Inc.). Fura-2 fluorescence at 509 nm generated by 340 nm excitation light (F340) and
380 nm light (F380) was collected every two seconds, and intracellular Ca
2+ levels are indicated by
F340/F380 ratio. To excite LOVSoc during light-on period, cells were continuously exposed to a 482 ±
9 nm light throughout each two-second interval immediately following the collection of every single
F380 and F340. After 1 min photostimulation (470 nm, 40 mW/mm
2), Ca2+ concentrations in cells were
determined by using a Fura 2 calcium imaging calibration kit (ThermoFisher Scientific) as we rou-
tinely did in earlier studies (Wang, 2014; Zhou et al., 2010a; 2010b; 2013). The resulting data col-
lected with MetaFluor software (Molecular Devices) were then exported as txt file, analyzed with
Matlab, and plotted using the Prism 5 software.
NFAT-dependent luciferase reporter assay
HeLa cells were seeded in 24-well plates and transfected after reaching 40–50% confluence. mCh-
LOVSoc, the firefly luciferase reporter gene (NFAT-Luc) and Renilla luciferase gene (pRL-TK) were
co-transfected using Lipofectamine 3000. 24 hr posttransfection, cells were treated with PMA (1 mM)
and/ or blue light (pulse of 30 s for every 1 min, 40 mW/mm2). Three duplicates were used for each
treatment. After 8 hr, cells were harvested and luciferase activity was assayed by using the Dual
Luciferase Reporter Assay System (Promega) on a Synergy luminescence microplate reader (BioTek,
Winooski, VT, USA). Renilla luciferase is used as control reporter for counting transfected cells and
normalizing the luminescence signals. The ratio of firefly to renilla luciferase activity was calculated
and normalized to un-treated control group.
Electrophysiological measurements
HEK EPC10 USB double patch amplifier controlled by Patchmaster software (HEKA Elektronik) was
used for data collection. Conventional whole cell recordings were used to measure current in
HEK293-ORAI1 stable cells transiently expressing mCh-LOVSoc as previously described (Ma, 2015).
After the establishment of the whole-cell configuration, a holding potential of 0 mV were applied. A
50 ms step to  100 mV followed by a 50 ms ramp from  100 to +100 mV was delivered every 2 s.
The intracellular solution contained (mM): 135 Cs aspartate, 6 MgCl2, 10 EGTA, 3.3 CaCl2, 2 Mg-
ATP, and 10 HEPES (pH 7.2 by CsOH). The free Ca2+ concentration in this pipette solution is esti-
mated to be 100 nM based on calculations from http://www.stanford.edu/~cpatton/webmaxcS.htm.
The extracellular solutions contained (mM): 130 NaCl (or N-methyl-D-glucamine, NMDG+), 4.5 KCl,
20 CaCl2, 10 TEA-Cl, 10 D-glucose, and 5 Na-HEPES (pH 7.4). A 10 mV junction potential compensa-
tion was applied to correct the liquid junction potential between the pipette solution relative to
extracellular solution. Currents from at least 6 cells for each condition were collected. HEKA Fitmas-
ter and Matlab 2014a software were used for data analysis.
Isolation, culture, and retroviral transduction of mouse primary T cells
Platinum-E (Plat-E) retroviral packaging cell Line (Cell Biolabs, Inc, San Diego, CA) was maintained in
Dulbecco modified Eagle medium (DMEM) supplemented with 10% fetal calf serum (FCS), 1% peni-
cillin/streptomycin, and 1% glutamine. Plat-E cells were transiently transfected using Lipofectamine
3000 (Life Technologies) and retroviral stocks were collected twice at 24-hr intervals beginning 48 hr
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after transfection. Retrovirus-containing medium was centrifuged at 20 000 rpm for 2 hr at 4˚C in a
Beckman SW28 swinging bucket rotor lined with an Open-Top polyclear centrifuge tube (Seton, Pet-
aluma, CA). The retroviral pellet was resuspended in DMEM and retrovirus was titered by transduc-
tion of mouse T cells with serial dilutions of retrovirus in the presence of 8 mg/ml polybrene (EMD
Millipore, Merck KGaA, Darmstadt, Germany). 48 hr posttransduction, percentage of infected cells
was determined by flow cytometric analysis of EGFP expression. The titer was calculated by multipli-
cation of the total number of EGFP-positive cells with the dilution factor of the retroviral
supernatant.
Naive CD4+ T cells were purified (>95% purity) by negative selection (Invitrogen) with Mouse
Depletion Dynabeads (Life Technologies, Grand Island, NY) from RBC-lysed single-cell suspensions
of pooled spleen and lymph nodes isolated from 6-week-old female C57BL/6 mice. For stimulation,
purified CD4+ T cells were cultured in DMEM supplemented with 10% heat-inactivated fetal bovine
serum, 2 mM L-glutamine, penicillin-streptomycin, non-essential amino acids, sodium pyruvate, vita-
mins, 10 mM HEPES, and 50 mM 2-mercaptoethanol. Cells were plated at ~106 cells per ml in 6-well
plates coated with anti-CD3 (clone 2C11, BioLegend, San Diego, CA, USA) and anti-CD28 (clone
37.51, BioLegend) (1 mg/ml each) by pre-coating with 100 mg/ml goat anti-hamster IgG (MP Biomed-
icals, Santa Ana, CA, USA). After 48 hr, cells were removed from the TCR signal and re-cultured at a
concentration of 5x105 cells/ in T cell media supplemented with 20 U/ml recombinant human IL-2
(rhIL-2). For retroviral transduction, CD4+ T cells were re-suspended in concentrated viral superna-
tant containing 8 mg/ml polybrene and rhIL-2 and centrifuged at 2,000 x g for 90 min at 32˚C then
put back to the incubator. On day 5–6, GFP+ cells were either left untreated (resting), or re-stimu-
lated with PMA (15 nM) and ionomycin (0.5 mM), or subjected to blue light pulse for 6–8 hr (30 s
pulse for every 1 min, 10–40 mW/mm2), or treated with both PMA and blue-light pulse for 6–8 hr.
Expression of cytokine production was assessed by real-time PCR and ELISA as described below.
Real-time PCR analyses
Total RNA was isolated from transduced CD4+ T cells and first-strand cDNA synthesis was per-
formed using total RNA, oligo-dT primers and reverse transcriptase II according to manufacturer’s
instructions (Invitrogen). Real-time PCR was performed using the SYBR Green ER qPCR Super Mix
Universal (Invitrogen) kit with specific primers using the ABI Prism 7000 analyzer (Applied Biosys-
tems). The sequences of the primers are as follows,
Primers for mouse Gapdh
Forward: 5’-TTGTCTCCTGCGACTTCAACAG-3’
Reverse: 5’-GGTCTGGGATGGAAATTGTGAG-3’
Primers for mouse interleukin 2 (Il-2)
Forward: 5’-TGAGCAGGATGGAGAATTACAGG-3’
Reverse: 5’-GTCCAAGTTCATCTTCTAGGCAC-3’
Primers for mouse interferon gamma (Ifn-g)
Forward: 5’-ATGAACGCTACACACTGCATC-3’
Reverse: 5’-CCATCCTTTTGCCAGTTCCTC-3’
Quantification of cytokines and insulin production by enzyme-linked
immunoassay (ELISA)
Supernatants of transduced CD4+ T cells were collected at indicated time after stimulation. Cytokine
concentrations were measured by using the mouse IL-2 (OptEIA #555148, BD Biosciences Inc., San
Jose, CA, USA) and IFN-g ELISA kits (#88–7314, eBiosciences Inc., San Diego, CA, USA). ELISA
assays were performed according to the manufacturer’s instructions. In brief, 96-well plate was pre-
coated with the capture antibody (1:500 in coating buffer) at 4˚C overnight. On the next day, the
plate was washed with PBS/0.1%Tween 20 and blocked with 1%BSA/PBS or ELISA/ELISPOT diluent
buffer for 2 hr at room temperature (RT). Diluted supernatants and cytokine standards were then
applied to the plate and incubated for 2 hr at RT. The plate was then washed and incubated with
biotin-conjugated detection antibody (1:1000 in 1%BSA/PBS or ELISA/ELISPOT diluent buffer) for
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1 hr at RT. Next, the plate was washed and incubated with poly-HRP streptavidin (1:5000 in diluent
buffer, Thermo Scientific) for 30 min. The plate was finally washed and incubated with the tetrame-
thylbenzidine substrate solution (Sigma-Aldrich) and the reaction was stopped with 2 M H2SO4. For
insulin reporter assay, 3x105 transfected HEK293T cells were cultivated in poly-L-lysine coated 24-
well pates and starved in serum-free culture medium for 24 hr to ensure minimal activation of Ca2+
dependent pathways. On the day of experiment, cells were washed with PBS and maintained in
serum-/glucose-starved Krebs buffer (118 mM NaCl, 4.7 mM KCl, 1.2 mM KH2PO4, 1.2 mM MgSO4,
4.2 mM NaHCO3, 2 mM CaCl2, 10 mM HEPES and 0.1 mg/ml BSA, pH7.4) with or without light stim-
ulation. Supernatants were collected for insulin ELISA detection using a human insulin ELISA kit
(KAQ1251, Life Technologies) according to the manufacture’s instructions. Absorbance of each well
was recorded at 450 nm. The absorbance of the standard sample was used to construct the standard
curve.
Detection of activated caspase-1 and mature IL-1b
THP-1 cells from ATCC were maintained in RPMI-1640 medium containing 10% FBS and 0.05 mM 2-
mercaptoethanol. Differentiated THP-1 cells were transduced with lentiviruses encoding LeGO-mCh-
LOVSoc. THP-1 cells (5  105) were seeded in 24-well plates and cultured overnight, followed by
priming with 100 ng/mlLPS for 3 hr and stimulating with Nigericin (10 mM) for 6 hr with or without
blue light stimulation. Medium from each well was mixed with 500 ml methanol and 125 ml chloro-
form, vortexed, and centrifuged for 5 min at 16,000  g. The supernatant of each sample was
removed and 500 ml methanol was added. Samples were centrifuged again for 5 min at 16,000  g.
Next, supernatants were removed and pellets were dried for 5 min at 50˚C. 80 ml loading buffer was
added to each sample, followed by boiling for 10 min prior to SDS-PAGE and immunoblot analysis
with antibodies for the detection of activated caspase-1 (D7F10; Cell Signaling). The amounts of
processed IL-1b were measured using a human IL-1b ELISA kits (R&D Systems) according to the man-
ufacturer’s instructions. Adherent cells in each well were lysed with the RIPA lysis buffer (50 mM Tris-
HCl, pH 8.0, with 150 mM sodium chloride, 1.0% Igepal CA-630 (NP-40), 0.5% sodium deoxycholate,
and 0.1% sodium dodecyl sulfate) with a protease inhibitors cocktail tablet (Roche), followed by
immunoblot analysis to determine the cellular content of various proteins.
Recombinant protein expression and purification
BL21 (DE3) E.coli cells (EMD Millipore) were transformed with plasmids encoding MBP-LOVSoc or
GB1-ORAI1-CT, and grown at 37ºC in LB medium with 100 mg/L of ampicillin. Protein expression
was induced by the addition of 500 mM IPTG when OD600 of the culture reached between 0.6 and
0.8. After IPTG induction, MBP-LOVSoc was incubated at 16ºC for additional 6–8 hr, whilst GB1-
ORAI1CT incubated at 37ºC for 3–4 hr. Harvested cells were resuspended in 1X Phosphate Buffered
Saline (PBS) and sonicated. The cellular debris was clarified by centrifugation. For His6-tagged GB1-
ORAI1-CT, the cell lysates were applied to Ni2+-nitrilotriacetic acid (Ni-NTA)-agarose resin (Qiagen).
Bound recombinant proteins were eluted in PBS containing 250 mM imidazole and 1 mM TCEP.
MBP and MBP-LOVSoc were purified through affinity purification with amylose resin (New England
Biolabs) and finally eluted by PBS buffer containing 25 mM maltose and 1 mM TCEP. The proteins
were further purified by gel filtration on Superose 6 10/300 GL or Superdex 200 10/300 GL columns
(GE Healthcare).
Pulldown and coimmunoprecipitation (CoIP) experiments
For MBP pulldown assay, 400 ml 1 mg/ml of MBP (used as negative control) or MBP-LOVSoc was
immobilized on 400 ml slurry of the amylose resin (New England Biolabs), and incubated with each
800 mg recombinant GB1-ORAI1-CT proteins in 1 ml PBS buffer containing 1 mM TCEP. The mix-
tures were divided into two groups: one group is constantly exposed to an external blue LED (470
nm, 40 mW/mm2) for 4 hr at 4˚C, and then followed by ten-time washing with PBS to minimize non-
specific binding; whereas the other group was similarly treated except that all steps were performed
in the dark. After extensive wash, the resin was finally mixed with 100 ml PBS and 4x SDS gel loading
buffer, heated at 100˚C for 10 min, and briefly centrifuged prior to gel electrophoresis. Samples
were separated on 15% SDS-PAGE or 4–12% gradient NuPAGE. Bound proteins were visualized on
SDS-PAGE after Coomassie Brilliant Blue R-250 staining.
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For immunoprecipitation, HEK293 cells co-transfected with FLAG-ORAI1 and mCh-LOVSoc were
lysed with 1x RIPA buffer containing protease inhibitor cocktails. Extracts were incubated for 1 hr
with anti-FLAG M2 affinity resin (A2220, Sigma) and the mixture was thoroughly washed with 1x
RIPA buffer, denatured and eluted with 1x SDS sample buffer (62.5 mM Tris-HCl, pH 6.8, 2% SDS,
10% (v/v) glycerol, and 0.002% bromphenol blue). For light-stimulated groups, all steps were per-
formed by exposing to an external blue LED (470 nm, 40 mW/mm2).
The UCNPs synthesis and modifications
All starting materials were obtained from commercial supplies and used as received. Rare earth
oxides Y2O3 (99.9%), Yb2O3 (99.9%), Tm2O3 (99.9%), trifluoroacetic acid (99%), 1-octadecene (ODE)
(>90%), oleic acid (90%), 1-ethyl-3-(3-dimethylaminopropyl) carbodiimide hydrochloride (EDCHCl),
N-hydroxysulfosuccinimide sodium salt (sulfo-NHS) and poly(acrylic acid) (PAA, Mw 1,800) were pur-
chased from Sigma-Aldrich. All other chemical reagents with analytical grade were used directly
without further purification.
The size and morphology of UCNPs were determined at 200 kV at a JEM-2010 low to high- reso-
lution transmission electron mircroscope (JEOL Inc., Peabody, MA, USA). The UCNP samples were
dispersed in hexane and dropped on the surface of a copper grid for TEM test. The upconversion
luminescence emission spectra were recorded on a Fluoromax-3 spectrofluorometer (Horiba Scien-
tific, Irvine, CA, USA) that was equipped with a power adjustable collimated CW 980 nm laser. All
the photoluminescence studies were carried out at room temperature.
The b-NaYF4:Yb,Tm core UCNPs were prepared using a modified two-step thermolysis method
(Mai et al., 2006). In the first step, the CF3COONa (2 mmol) and required Ln(CF3COO)3 (0.5 mmol
in total) precursors were mixed with oleic acid (5 mmol), oleyl amine (5 mmol) and 1-octadecene (10
mmol) in a two-neck reaction flask. The mol-percentage of Tm(CF3COO)3 was fixed at 0.5%, Yb
(CF3COO)3 was employed in 80%, and Y(CF3COO)3 was used of 19.5%. The slurry mixture was
heated to 110˚C in order to form a transparent solution. This was followed by 10 min of degassing
to remove the oxygen and water. The flask was then heated to 300˚C at a rate of 15˚C per min under
dry argon flow, and remained at 300˚C for 30 min. The a-NaLnF4 intermediate UCNPs were acquired
by cooling down the reaction solution to room temperature, followed by centrifugation with exces-
sive ethanol. In the second step, the a-NaYF4:Yb, Tm UCNPs were re-dispersed in oleic acid (10
mmol) and 1-octadecene (10 mmol) along with CF3COONa in a two-neck flask. After degassing at
110˚C for 10 min, the flask was heated to 325˚C at a rate of 15˚C per min under dry argon flow, and
remained at 325˚C for 30 min. The b-NaYF4:Yb,Tm UCNPs were then centrifugally separated from
the cooled reaction media and suspended in 10 ml of hexane as the stock solution for further use.
In the thermolysis reaction, as-synthesized b-NaYF4:Yb, Tm UCNPs served as crystallization seeds
for the epitaxial growth of undoped b-NaYF4 shell. Typically, a stock solution of b-NaYF4:Yb, Tm
UCNPs (5 ml, ca. 0.26 mmol/L core UCNPs) was transferred into a two-neck flask and hexane was
sequentially removed by heating. Then CF3COONa and Y(CF3COO)3 (0.5 mmol) were introduced as
UCNP shell precursors with oleic acid (10 mmol) and 1-octadecene (10 mmol). After 10 min of
degassing at 110˚C, the flask was heated to 325˚C at a rate of 15˚C/min under dry argon flow and
was kept at 325˚C for 30 min. The products were precipitated by adding ethanol to the cooled reac-
tion flask. After centrifugal washing with hexane/ethanol, the core/shell UCNPs were re-dispersed in
10 ml of hexane for further use.
The synthesis of UCNPs-Stv
The hydrophobic UCNPs were first treated by surface ligand exchange using a modified literature
method (Dong et al., 2011). Briefly, nitrosonium tetrafluoroborate (NOBF4, 0.20 g) was dissolved in
dimethylformamide (DMF, 5 ml), and b-core/shell UCNPs in hexane stock solution (1 ml) was added,
followed by 4 ml hexane and 2 hr of stirring at room temperature. Then BF4
- capped UCNPs were
precipitated by adding isopropanol (5 ml), and purified by 2 cycles of centrifugal wash with DMF.
Subsequently, all UCNPs precipitates were dispersed in poly(acrylic acid)/DMF (PAA, Mw 1800, 10
mg/ml, 5 ml) solution to replace surface BF4
- by PAA. After overnight incubation, the PAA coated b-
NaYF4:Yb,Tm/NaYF4 UCNPs were purified by centrifugal wash with deionized (DI) water.
The streptavidin and zwitterion ligands (Muro et al., 2010) were conjugated to UCNPs-PAA sur-
face by EDC (1-Ethyl-3-(3-dimethylaminopropyl)-carbodiimide) coupling approach. Generally, 50 mg
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hydrophilic PAA-coated UCNPs in 5 ml DI water were activated by EDC (50 mg) and NHS (10 mg) to
form succinimidyl ester. After stirring at room temperature for 2 hr, the nanoparticles were collected
by centrifugation followed by washing with DI water. The generated nanoparticles were then re-dis-
persed into 5 ml DI water, followed by adding 150 mg streptavidin and the mixture was further
stirred at room temperature for 4 hr. Next, 100 mg zwitterion ligand was introduced to the solution.
After overnight stirring at room temperature, the UCNPs-Stv were purified by washing with DI water,
centrifugation and dispersion in DI-water for further use.
In vitro LOV2 domain activation mediated by UCNPs-Stv following NIR
light stimulation
5 ml LOV2 or MBP-LOVSoc proteins were concentrated to 0.5 ml at a concentration of 50–100 mM
using centrifugal filter devices with a cutoff of 10 kDa. The UV-Vis spectra were recorded with a Shi-
madzu or Nanodrop 2000 spectrophotometer (Thermo Scientific, Waltham, MA, USA). The absor-
bance was recorded before and after the introduction of UCNPs-Stv. 10 mg of UCNPs-Stv was
added to make a final concentration of 20 mg/ml. The mixed solution was then transferred to a thin
glass tube (with a diameter comparable to the CW laser spot) and subjected to 980 nm CW laser
excitation (15 mW/mm2) for 1 min. The control sample was exposed to blue light (470 nm, 40 mW/
mm2) for 1 min. After light stimulation, the absorbance was monitored every 30–300 s till the LOV2
domain fully returned to its dark state.
Fourier transform infrared spectroscopy (FT-IR)
20 mg of UCNPs with different surface modifications were mixed with 100 mg KBr, and then
grounded into fine powder in a mortar. A piece of pre-cut cardboard was placed on top of a stain-
less steel disk and the cutout hole was filled with the finely ground mixture. A second stainless steel
disk was put on top and the sandwich disks were transferred onto the pistil in the hydraulic press to
obtain a homogenous and transparent film. The samples were then inserted into the IR sample
holder for analysis. Black background (KBr film only) was subtracted from the corresponding
spectrum.
Quantification of upconversion quantum efficiency
The upconversion quantum efficiency (QE) is used to precisely measure the upconversion ability of
the characterized materials, which is defined as the fraction of the absorbed photons that success-
fully employed to generate upconversion emission. The upconversion QE was calculated based on
the following equation: QE=i*QY; where QY represents the quantum yield and i equals to 3 as Tm3+
excited state produces three-photon luminescence at 480 nm (from 1D2 state to
3H6 state). The
upconversion QY was first measured on a relative basis, using a known QY (3.2%) sample of a-
NaYF4:Yb,Er @CaF2 as a standard (Punjabi et al., 2014). The following equation was used to calcu-
late the QY:
QYSample ¼ QYref
Esample
Eref
 
Aref
Asamples
 
,
where (E) is the integrated emission intensity at 480nm, (A) is the absorption at 980 nm. The
upconversion QE of the 40-nm b-NaYF4:Yb,Tm@b-NaYF4 UCNPs in the blue region was determined
to be 2.7% at the power density of 10 W/cm2.
Fluorescence imaging with UCNPs
Imaging of UCNPs-Stv targeted to HeLa cells transfected with mCh-
ORAI1StrepTag
Transfection reagent (100 ng of pcDNA-mCh-ORAI1StrepTag in 50 mL opti-MEM) was mixed with lipo-
fectamine solution (2 mL of lipofectamine in 50 mL opti-MEM). 5 min later, the plasmid mixture was
added into petri dish with 0.1 million HeLa cells. The cells were incubated with transfection reagent
in opti-MEM for 4 hr, returned to DMEM and allowed for further growth of 16 hr. 100 mL of UCNPs-
Stv PBS solution was introduced into the cell culture media and incubated for 2 hr, followed by
washing and re-addition of opti-MEM for imaging. For imaging, Images were recorded on a LSM7
MP microscope (Zeiss) equipped wavelength adjustable coherent lasers with 60 water immersion
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objective lens. mCherry was excited at 740 nm and emission was detected from 610 to 650 nm.
While UCNPs was excited at 980 nm and emission was detected from 450 to 500 nm.
Imaging of transfected HeLa cells in the presence of UCNPs-Stv
HeLa cells were cotransfected with a total of 500 ng DNA (200 ng of pTriEX-mCh-LOVSoc, 200 ng of
pcDNA3.1-mCh-ORAI1-StrepTag, 100 ng of pGP-CMV-GCaMP6S-CAAX or 100 ng NFAT11-460-GFP
in opti-MEM) as described above. 16 hr posttransfection and 2 hr prior to imaging, 20 mg of
UCNPs-Stv PBS solution was introduced into the cell culture media. For imaging, Petri dish was
mounted on a Leica TCS SP 2 confocal microscope equipped with a 63oil objective. mCherry was
excited at 590 nm and emission was detected from 610 to 670 nm. A 488-nm laser with minimum
power was used to acquire GFP signals whilst a 590-nm laser was applied to acquire mCherry sig-
nals. All images were collected at a scanning rate of 400 Hz. 980 CW laser was introduced into the
system with a power density of 15 mW/mm2, and each irradiation takes 5–10 s. The relatively slow
onset of Ca2+ influx and NFAT nuclear translocation provided us a time window to quickly capture
the green signals without noticeably activating LOVSoc during image acquisition. This allows us to
confidently apply NIR light to monitor Ca2+ influx and NFAT nuclear translocation.
Bioluminescence and thermal imaging
HeLa cells were transfected with NFAT-Luc with and without the Opto-CRAC construct LOVSoc, as
indicated. 48 hr after transfection, 5  105 cells suspended in 200 mL DMEM with 1 mM PMA were
mixed with 10 mg UCNPs-Stv, then implanted i.v. into BALB/c mice (female; 4–8 weeks; injected
position: upper thigh, as indicated in red circle; from Jackson Laboratory). The hairs on the back of
the mice were shaved, whilst the hairs on the belly remained unshaved. The implanted regions were
subject to 980 nm CW laser irradiation (50 mW/mm2, 30 sec every 1 min for a total of 25 min), during
anesthesia using ketamine/xylazine (100 mg/kg, 10 mg/kg, i.v.). Five hours later, the cells implanted
area was injected with D-luciferin (s.c., 100 mL, 15 mg/ml in PBS) and imaged 20 min later with an
IVIS-100 in vivo imaging system (2-min exposure; binning = 8). Luciferase luminescence was plotted
as false color with rainbow-scale bar set as the same for all acquired images. For thermal imaging,
BALB/c mice were immobilized and exposed to 50 mW/mm2 980 nm CW laser under the same con-
dition as we carried out for the in vivo luciferase experiment. Images at two-minute intervals were
taken by a thermal imaging camera (FLIR Instruments).
Ex vivo cross-presentation assay and OT-I T-cell activation
To obtain murine bone marrow-derived dendritic cells (DCs), bone marrow cells were washed out of
the femurs of adult mice in RPMI-1640 using a syringe and a 25-gauge needle and depleted of red
blood cells. Bone marrow cells (5x105 cells/well) in 6-well plate were cultured in RPMI-1640 contain-
ing 2 mM-L-glutamine,100 IU/ml penicillin,100 mg/ml streptomycin, 10% FCS,50 mM b-ME,20 ng/ml
GM-CSF and 200 IU/ml IL-4 for dendritic cell differentiation. Bone marrow cells were transduced
with MSCV expressing viral vector pMIG-mCh-LOVSoc-IRES-ORAI1StrepTag on day 3 at MOI of 20 for
6 hr. Next, 75% of the media and non-adherent cells were removed and replaced with fresh culture
medium. On day 5, transduced DCs were gently dislodged and pulsed for 3 hr at 37˚C with 2 mg/ml
OVA257–264 peptide (GenScript) and 1 mg/ml UCNP-Stv nanoparticles. Cells were then washed to
remove unattached peptide and nanoparticles. To generate OT-I CD8 T cells, spleens and lymph
nodes (LN) of OT-1 Rag1-/- mice (purchased from the Jackson Laboratory) were pressed through a
70 mm cell strainer (BD Falcon). Untouched CD8 T cells were sorted by using mouse CD8 T Cell Iso-
lation Kit (Miltenyi Biotec). 2x104 irradiated peptide loaded UCNPs-Stv/OVAp Opto-CRAC DCs
were seeded in triplicates in 96-well U-bottom plates containing 5x104 purified OT-I CD8 T cells in a
total volume of 200 ml and co-cultured for 5 days with or without NIR light stimulation for 16h (1 min
pulse, 15 mW/mm2). T cell proliferation was determined by labeling cultured cells with [3H] thymi-
dine at a concentration of 1 mCi/mL for 16 hr and the radioactivity was measured using a liquid scintil-
lation counter (PerkinElmer). To detect DCs maturation and migration, NIR-stimulated or
unstimulated UCNPs-Stv Opto-CRAC DCs were stained with FITC-CD11c, PE-MHC-I, APC-MHC-II,
PE-CD86 and PE-CCR7 and then subjected to flow cytometry analysis 3 days post-transduction. For
intracellular IFN-g staining, OT-I CD8 T cells were incubated with UCNPs-Stv/OVAp Opto-CRAC
DCs for 6 hr at 37˚C in the presence of GolgiStop (monensin) (BD Pharmingen). Cells were then
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stained with surface marker using APC-CD8a antibody for 15 min on ice and permeabilized using
cytofix/cytoperm (BD Biosciences) for 30 min on ice. Permeabilized cells were resuspended in BD
Perm/Wash buffer (BD Biosciences) and stained with PE-anti-IFN-g antibody for 20 min. Samples
were run on a BD LSRII Flow Cytometer and analyzed by BD FACSDiva software.
Adoptive cell transfer in murine B16-OVA melanoma models
B16-OVA is an OVA-transfected clone derived from the murine melanoma cell line B16 (ref. 35).
B16-OVA cells were cultured and maintained in Dulbecco’s modified Eagle medium (HyClone) sup-
plemented with 10% heat-inactivated fetal bovine serum (FBS), 100 IU/ml penicillin, 100 mg/ml
streptomycin under 37˚C in 5% CO2. B16-OVA cells (1x106) were injected s.c. into the flank region
or i.v. via tail vein of Rag1-/- mice (purchased from the Jackson Laboratory) (Overwijk and Restifo,
2001). 3 days later, mice were injected i.v. with 2105 Opto-CRAC DCs treated with UCNPs-Stv and
the surrogate tumor antigen OVA257-264. 1.510
6 OT-I T cells labeled with CellTrace far red CFSE
were i.v. injected into tumor-bearing mice. Briefly, cells were incubated at 1x106 cells/ml in CFSE at
a final concentration of 1 mM for 20 min at room temperature. The labeling reaction was stopped by
adding the same volume of FBS. Recipient Rag1-/- mice were subjected to the excitation of NIR laser
(8 hr per day, 0.5–1 min ON/OFF pulse, 30 mW/mm2) or shielded from NIR (control group) for 6
days to stimulate Opto-CRAC DC maturation, with the initial two days concentrating more on areas
nearby the draining lymph nodes of restricted mice. For in vivo T cell proliferation, spleen and drain-
ing popliteal and inguinal LNs were harvested and injected with collagenase D (1 mg/ml; Boeh-
ringer-Mannheim, Mannheim, Germany) in RPMI and 10% FBS for 20 min at 37˚C. Digested LN or
spleen were filtered through a stainless-steel sieve, and the cell suspension was washed twice in PBS
and 5% FBS. CFSE-labeled OT-I CD8 T cells were analyzed by flow cytometry as described above.
Tumor growth was measured at indicated time points using calipers shown in growth curve using
the equation of V = Lx W2/2. Lungs were isolated and tumor foci of lung melanomas were counted
from tumor-bearing mice shielded or exposed to NIR pulse from day 3–9 after B16-OVA tumor cell
injection.
Histology analyses
Hela cells and UCNPs were subcutaneously implanted into upper thigh of BALB/c mice, followed by
980 nm CW laser irradiation (50 mW/mm2, 30 sec every 1 min for a total of 25 min), during anesthe-
sia using ketamine/xylazine (100 mg/kg, 10 mg/kg, i.v.). Two weeks after subcutaneous implantation,
mice were sacrificed and tissue samples under skin at the injection position were collected. Routine
Hematoxylin and Eosin staining (H&E) was performed by University of Massachusetts Medical School
morphology core.
Data analyses
The fluorescence images were analyzed with the NIS-Elements imaging software (Nikon) or the
Image J package (NIH) with the intensities plotted using the GraphPad Prism 5 graphing and statisti-
cal software. The mean lifetime of fluorescence signal change was calculated with a single exponen-
tial decay equation F(t)=F(0)*eb(-t/t). Quantitative data are expressed as the mean and standard
deviation of the mean (s.e.m.) unless otherwise noted. Paired Student’s t-test was used throughout
to determine statistical significance. *P<0.05; **P<0.01; ***P<0.001, when compared to control or
WT.
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